FUSN Fusion Pharmaceuticals Inc

Price (delayed)

$8.29

Market cap

$351.97M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$18.89

Enterprise value

$316.52M

Highlights
The quick ratio has surged by 195% year-on-year and by 59% since the previous quarter
The EPS has plunged by 53% YoY
Fusion Pharmaceuticals's net income has decreased by 9% QoQ

Key stats

What are the main financial stats of FUSN
Market
Shares outstanding
42.46M
Market cap
$351.97M
Enterprise value
$316.52M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.24
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$82.84M
EBITDA
-$82.18M
Free cash flow
-$44.24M
Per share
EPS
-$18.89
Free cash flow per share
-$1.06
Book value per share
$6.67
Revenue per share
$0
TBVPS
$7.12
Balance sheet
Total assets
$297.31M
Total liabilities
$18.24M
Debt
$7.52M
Equity
$279.07M
Working capital
$226.24M
Liquidity
Debt to equity
0.03
Current ratio
30.7
Quick ratio
30.07
Net debt/EBITDA
0.43
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-27.6%
Return on equity
-28.7%
Return on invested capital
-64.8%
Return on capital employed
-28.6%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

FUSN stock price

How has the Fusion Pharmaceuticals stock price performed over time
Intraday
-14%
1 week
0%
1 month
1.34%
1 year
N/A
YTD
-29.45%
QTD
-22.67%

Financial performance

How have Fusion Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$46.91M
Net income
-$85.64M
Gross margin
N/A
Net margin
N/A
The operating income has plunged by 105% YoY and by 24% from the previous quarter
Fusion Pharmaceuticals's net income has decreased by 9% QoQ

Growth

What is Fusion Pharmaceuticals's growth rate over time

Valuation

What is Fusion Pharmaceuticals stock price valuation
P/E
N/A
P/B
1.24
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has plunged by 53% YoY
The P/B is 31% lower than the last 4 quarters average of 1.8
Fusion Pharmaceuticals's equity has decreased by 5% QoQ

Efficiency

How efficient is Fusion Pharmaceuticals business performance
The return on invested capital has increased by 45% since the previous quarter
FUSN's return on equity is up by 22% since the previous quarter
FUSN's ROA is up by 15% YoY and by 12% QoQ

Dividends

What is FUSN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for FUSN.

Financial health

How did Fusion Pharmaceuticals financials performed over time
The quick ratio has surged by 195% year-on-year and by 59% since the previous quarter
Fusion Pharmaceuticals's current ratio has soared by 60% from the previous quarter
Fusion Pharmaceuticals's debt is 97% less than its equity
Fusion Pharmaceuticals's equity has decreased by 5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.